3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Oropharyngeal Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, Extranodal NK-T-Cell
1
Lung Neoplasms
1
Fistula
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Anus Neoplasms
1
Interventions
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
romidepsin
1
decitabine and cedazuridine drug combination
1
Vincristine
1
Tomography, X-Ray Computed
1
Prednisone
1
Oxaliplatin
1
Gemcitabine
1
Etoposide
1
Doxorubicin
1
Cyclophosphamide
1
Clinical Trials, Phase II as Topic
1
Clinical Trials, Phase I as Topic
1
ASTX-660
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lymphoma, T-Cell, Peripheral
×
Tomography, X-Ray Computed
×
Clear all
NCT06362148
2026-05-01
CIRCULATE
University of Aarhus
Active not recruiting
50 enrolled